Key result
Antigenic mimicry and dysregulated immunity drive RHD pathogenesis via T-cell, cytokine, and endothelial activation.
Why the study?
Chronic rheumatic heart disease is an under-recognised cause of cardiovascular morbidity and death needing clarification of its immunopathogenesis to inform earlier diagnosis, enhanced secondary prevention, and rational therapies.
This review synthesizes current understanding of the immune-mediated pathogenesis of rheumatic heart disease to inform future experimental models, biomarker identification, and immunomodulatory therapies.
Answers are grounded in this paper and cite their sources.
May guide immune biomarker development for RHD; leaves open prospective validation of targeted therapies.
Acute rheumatic fever is an immune-mediated sequela of Streptococcus pyogenes (group A Streptococcus ) infection, presenting with fever, arthritis, chorea, rash, and, crucially, carditis. Without effective secondary prophylaxis and care, acute rheumatic fever can progress to chronic rheumatic heart disease, a leading yet under-recognised cause of cardiovascular morbidity and death that disproportionately affects children and young adults aged 5–24 years in low-resource settings. Robust evidence implicates the role of antigenic mimicry–particularly between streptococcal M protein and cardiac or myocardial matrix proteins–together with dysregulated immune control in driving valvular injury. In this Review, we discussed mechanisms of rheumatic heart disease immunopathogenesis, highlighting the roles of T-cell responses, chemokine-guided recruitment to valves, cytokine dysregulation, endothelial activation, and stromal remodelling. We also analysed limitations of existing data and delineate strategies to develop experimental models, identify biomarkers, and define immunomodulatory targets that can inform earlier diagnosis, enhanced secondary prevention, and rational therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Lupieri et al. (2026) conducted a review in Rheumatic heart disease. Antigenic mimicry and dysregulated immune control drive rheumatic heart disease immunopathogenesis through T-cell responses, cytokine dysregulation, endothelial activation, and stromal remodelling.
Synapse has enriched 10 related papers. Consider them for comparative context: